GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Trials & Approvals Vaccine
GSK’s Meningococcal Combination Vaccine Clears All Primary Endpoints In Phase 3
2023-03-15
Trials & Approvals Phase 3 Trial
Astellas Clears Primary Endpoints In Prostate Cancer And Menopause Trials
2023-03-14
Trials & Approvals Migraine
Pfizer’s Fast-Acting Migraine Nasal Spray Takes Home US Approval
2023-03-13
Trials & Approvals Polivy
Roche’s Polivy Wins Support From FDA Adcom For Treating B-Cell Cancer
2023-03-10
Trials & Approvals Alzheimer's Disease
Lilly’s New Alzheimer’s Drug Suffers Setback as Phase 3 Results Fall Short of Expectations
2023-03-10
Trials & Approvals Mesoblast Limited
Mesoblast’s Resubmission Brings First-of-its-Kind Therapy One Step Closer to Approval
2023-03-09
Trials & Approvals Parkinson’s Disease
Praxis Stock Hits All-Time Low After Phase 2 Tremor Data Released
2023-03-06
Trials & Approvals RSV vaccines
Pfizer and GSK Neck and Neck for First FDA-Approved RSV Vaccine
2023-03-03
Trials & Approvals Rare Disease
Reata’s Groundbreaking Therapy for an Ultra-rare Neuromuscular Disease Secures FDA Approval
2023-03-02
Trials & Approvals RSV vaccines
Pfizer’s RSV Vaccine Wins Support From FDA Advisory Panel for Use in Older Adults
2023-03-01
Trials & Approvals Keytruda
Merck’s Keytruda Falls Short In Two Trials
2023-03-01
Trials & Approvals Hemophilia A
FDA Approves Sanofi and Sobi’s Once-Weekly Hemophilia A Med
2023-02-23
Trials & Approvals Gene Therapy
CSL’s Hemgenix Wins First Gene Therapy Approval For Hemophilia In Europe
2023-02-21
Trials & Approvals Immunoglobulin
Travere Snags Accelerated Approval for First Non-Immunosuppressive IgAN Therapy
2023-02-19
Trials & Approvals AMD
Apellis’ Syfovre Nets First FDA Approval For Geographic Atrophy
2023-02-18
1 … 3 4 5 6 7 … 50
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top